Recently, Jena Analytical Instruments (Jena) has entered into a partnership with Illumina. After the cooperation, Jena will enter the growing genotyping market.
The market is currently powered by Illumina, based on the 96-sample Infinium XT BeadChip, which provides ultra-high-throughput sample preparation to provide a solution.
"This partnership will further strengthen Jena's position in the genomics market," said Jena CEO Ulrich Krauss. “We look forward to working with Illumina and its customers on high-throughput genotyping solutions.â€
The agreement signed this time includes joint development and marketing. Jena's automation technology promises ultra-high-throughput genotyping, from hundreds of thousands to 1 million samples per year. Illumina's Infinium family's genotyping assay, BeadChip platform, guarantees high data quality, good reproducibility, and low error rates.
Together with the CyBio FeliX platform, capacity and sample throughput increase, while the software allows for a seamless transition. Protocol simplification, real-time data generation, analysis, on-demand QC reporting, etc. are some of the latest available features of the platform, and the interactive user interface is fully integrated with the next generation of Illumina LIMS.
Tetanus Vaccine,Hepatitis B Vaccine For Adults,Tetanus Booster,Td Vaccine
FOSHAN PHARMA CO., LTD. , https://www.foshanmedicine.com